26.44

1.97% -0.53

Pre-market: 26.44

Doximity Inc (DOCS)

Overview News Price History Option Chain Financials Why DOCS Down? Discussions Forecast

Doximity Inc stock is traded at $26.44, with a volume of 2.07M. It is down -1.97% in the last 24 hours and down -24.99% over the past month. Doximity Inc is a digital platform for U.S. medical professionals. The cloud-based platform provides members with tools specifically built for medical professionals, enabling them to collaborate with their colleagues, securely coordinate patient care, conduct virtual patient visits, stay up-to-date with the latest medical news and research, and manage their careers and on-call schedules.

Previous Close:

$26.97

Open:

$26.75

24h Volume:

2.07M

Relative Volume:

0.60

Market Cap:

$4.88B

Revenue:

$637.78M

Net Income/Loss:

$239.40M

P/E Ratio:

22.20

EPS:

1.1909

Net Cash Flow:

$307.21M

1W Performance:

+8.36%

1M Performance:

-24.99%

6M Performance:

-61.41%

1Y Performance:

-61.02%

1-Day Range:

$25.96

$26.92

1-Week Range:

$23.84

$27.06

52-Week Range:

$23.53

$76.51

Doximity Inc Stock (DOCS) Company Profile

Name

Doximity Inc

Sector

Healthcare (1106)

Industry

Health Information Services (49)

Phone

(650) 549-4330

Address

500 THIRD STREET, SUITE 510, SAN FRANCISCO

Employee

830

Twitter

Next Earnings Date

2024-11-07

Latest SEC Filings

DOCS's Discussions on Twitter

Compare DOCS vs VEEV, TEM, BTSG, HQY, WAY

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
DOCS Doximity Inc	26.44	4.98B	637.78M	239.40M	307.21M	1.1909
VEEV Veeva Systems Inc	188.48	30.56B	3.08B	860.33M	1.35B	5.1463
TEM Tempus Ai Inc	51.29	9.19B	1.27B	-245.03M	-245.36M	-1.4071
BTSG Brightspring Health Services Inc	41.96	7.33B	11.99B	24.18M	234.31M	0.2956
HQY Healthequity Inc	81.15	6.87B	1.15B	96.70M	-161.99M	1.09
WAY Waystar Holding Corp	26.93	5.09B	906.14M	-52.62M	89.62M	-0.3621

Doximity Inc Stock (DOCS) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Feb-09-26	Upgrade	Canaccord Genuity	Hold → Buy
Feb-06-26	Upgrade	JP Morgan	Underweight → Neutral
Jan-20-26	Upgrade	Wells Fargo	Equal Weight → Overweight
Jan-09-26	Initiated	RBC Capital Mkts	Outperform
Jan-08-26	Upgrade	Truist	Hold → Buy
Dec-15-25	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Dec-09-25	Initiated	Barclays	Overweight
Nov-21-25	Upgrade	Raymond James	Outperform → Strong Buy
Nov-13-25	Initiated	BMO Capital Markets	Market Perform
Oct-27-25	Upgrade	BofA Securities	Neutral → Buy
Oct-10-25	Downgrade	JP Morgan	Neutral → Underweight
Oct-01-25	Downgrade	Goldman	Neutral → Sell
Jul-09-25	Upgrade	Evercore ISI	In-line → Outperform
Jun-02-25	Upgrade	BTIG Research	Neutral → Buy
Feb-07-25	Upgrade	Leerink Partners	Market Perform → Outperform
Feb-07-25	Upgrade	Piper Sandler	Neutral → Overweight
Dec-20-24	Initiated	Stephens	Equal-Weight
Dec-04-24	Initiated	Mizuho	Neutral
Nov-15-24	Initiated	Goldman	Neutral
Nov-14-24	Upgrade	Morgan Stanley	Underweight → Equal-Weight
Nov-13-24	Downgrade	Canaccord Genuity	Buy → Hold
Nov-08-24	Upgrade	KeyBanc Capital Markets	Sector Weight → Overweight
Nov-08-24	Upgrade	Wells Fargo	Underweight → Equal Weight
Oct-15-24	Upgrade	Barclays	Equal Weight → Overweight
Aug-09-24	Upgrade	Needham	Hold → Buy
Jul-18-24	Downgrade	Wells Fargo	Equal Weight → Underweight
Apr-25-24	Upgrade	JP Morgan	Underweight → Neutral
Feb-26-24	Initiated	Leerink Partners	Market Perform
Jan-03-24	Initiated	Barclays	Equal Weight
Jan-02-24	Upgrade	BofA Securities	Underperform → Neutral
Aug-09-23	Downgrade	Guggenheim	Buy → Neutral
Aug-09-23	Downgrade	Needham	Buy → Hold
Aug-03-23	Downgrade	Piper Sandler	Overweight → Neutral
May-01-23	Downgrade	Wells Fargo	Overweight → Equal Weight
Jan-06-23	Downgrade	Morgan Stanley	Equal-Weight → Underweight
Oct-31-22	Initiated	Wells Fargo	Overweight
Oct-24-22	Initiated	Evercore ISI	In-line
Oct-13-22	Initiated	BTIG Research	Neutral
Sep-16-22	Initiated	KeyBanc Capital Markets	Sector Weight
Sep-07-22	Initiated	Truist	Hold
Aug-05-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-28-22	Initiated	Berenberg	Buy
May-18-22	Reiterated	BofA Securities	Neutral
May-18-22	Reiterated	Goldman	Buy
May-18-22	Reiterated	Guggenheim	Buy
May-18-22	Reiterated	Jefferies	Buy
May-18-22	Reiterated	Morgan Stanley	Equal-Weight
May-18-22	Reiterated	Needham	Buy
Apr-07-22	Initiated	Guggenheim	Buy
Apr-04-22	Initiated	BofA Securities	Neutral
Feb-11-22	Initiated	Goldman	Buy
Dec-14-21	Downgrade	JP Morgan	Neutral → Underweight
Dec-02-21	Initiated	Jefferies	Buy
Nov-17-21	Initiated	Robert W. Baird	Outperform
Nov-10-21	Reiterated	Canaccord Genuity	Buy
Nov-10-21	Reiterated	Goldman	Neutral
Nov-10-21	Reiterated	Morgan Stanley	Equal-Weight
Nov-10-21	Reiterated	Needham	Buy
Nov-10-21	Reiterated	Piper Sandler	Overweight
Aug-26-21	Downgrade	JP Morgan	Overweight → Neutral
Jul-19-21	Initiated	Canaccord Genuity	Buy
Jul-19-21	Initiated	Goldman	Neutral
Jul-19-21	Initiated	JP Morgan	Overweight
Jul-19-21	Initiated	Morgan Stanley	Equal-Weight
Jul-19-21	Initiated	Piper Sandler	Overweight
Jul-19-21	Initiated	Raymond James	Outperform
Jul-19-21	Initiated	SVB Leerink	Outperform
Jul-19-21	Initiated	William Blair	Outperform

View All

Doximity Inc Stock (DOCS) Latest News

Mar 04, 2026

DOCS SEC FilingsDoximity Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 04, 2026

Doximity Analysts Set $44.50 Average Price Target - National Today

Mar 04, 2026

Mar 03, 2026

Atlassian, C3.ai, Doximity, Braze, and Zeta Global Stocks Trade Up, What You Need To Know - Yahoo Finance

Mar 03, 2026

DOCS (NYSE: DOCS) insider to sell 2,000 shares via option exercise - Stock Titan

Mar 03, 2026

Mar 02, 2026

Is Doximity’s (DOCS) ViVE 2026 Pitch a Clue to Its Telehealth Moat? - simplywall.st

Mar 02, 2026

Bentley Systems, Guidewire Software, Health Catalyst, and Doximity Shares Skyrocket, What You Need To Know - Finviz

Mar 02, 2026

Intech Investment Management Trims Doximity Holdings - National Today

Mar 02, 2026

Ad Vital’s Dr. Shitel Patel Shares AI Prompting Strategies for Patient Growth in Doximity Article - FinancialContent

Mar 02, 2026